Comprehensive Solid Tumor Panel

This assay tests for amplifications, fusions, and small variants (single nucleotide and <50 nucleotide insertion/deletions) in ~160 genes associated with response to therapy and qualifications for clinical trials for most solid tumors, including breast, central nervous system, lung, colorectal, and melanoma tumors, among others.

This test will be available soon. For additional information, please contact us.